Stefania S. Moro - Publications

Affiliations: 
Psychology York University, Toronto, Ontario, Canada 

96 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Moro SS, Gorbet DJ, Steeves JKE. Brain Activation for Audiovisual Information in People With One Eye Compared to Binocular and Eye-Patched Viewing Controls. Frontiers in Neuroscience. 14: 529. PMID 32508588 DOI: 10.3389/Fnins.2020.00529  1
2019 Wong NA, Rafique SA, Moro SS, Kelly KR, Steeves JKE. Altered white matter structure in auditory tracts following early monocular enucleation. Neuroimage. Clinical. 24: 102006. PMID 31622842 DOI: 10.1016/J.Nicl.2019.102006  1
2018 Moro SS, Steeves JKE. Intact Dynamic Visual Capture in People With One Eye. Multisensory Research. 31: 675-688. PMID 31264607 DOI: 10.1163/22134808-20181311  1
2018 Moro SS, Harris LR. Vestibular-somatosensory interactions affect the perceived timing of tactile stimuli. Experimental Brain Research. PMID 30062442 DOI: 10.1007/S00221-018-5346-8  0.76
2018 Moro SS, Steeves JKE. Normal temporal binding window but no sound-induced flash illusion in people with one eye. Experimental Brain Research. PMID 29675714 DOI: 10.1007/S00221-018-5263-X  1
2018 Moro SS, Hoover AEN, Steeves JKE. Short and long-term visual deprivation leads to adapted use of audiovisual information for face-voice recognition. Vision Research. PMID 29567099 DOI: 10.1016/J.Visres.2018.01.009  1
2018 Moro SS, Steeves JKE. Audiovisual plasticity following early abnormal visual experience: Reduced McGurk Effect in people with one eye. Neuroscience Letters. PMID 29474874 DOI: 10.1016/J.Neulet.2018.02.031  1
2017 Wong NA, Rafique SA, Kelly KR, Moro SS, Gallie BL, Steeves JKE. Altered white matter structure in the visual system following early monocular enucleation. Human Brain Mapping. PMID 28963811 DOI: 10.1002/Hbm.23831  1
2016 Federico S, Ciancetta A, Porta N, Redenti S, Pastorin G, Cacciari B, Klotz KN, Moro S, Spalluto G. 5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors. European Journal of Medicinal Chemistry. 108: 529-41. PMID 26717203 DOI: 10.1016/J.Ejmech.2015.12.019  0.01
2015 Squarcialupi L, Catarzi D, Varano F, Betti M, Falsini M, Vincenzi F, Ravani A, Ciancetta A, Varani K, Moro S, Colotta V. Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor. European Journal of Medicinal Chemistry. 108: 117-133. PMID 26638043 DOI: 10.1016/J.Ejmech.2015.11.015  0.01
2015 Federico S, Redenti S, Sturlese M, Ciancetta A, Kachler S, Klotz KN, Cacciari B, Moro S, Spalluto G. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives. Plos One. 10: e0143504. PMID 26625265 DOI: 10.1371/Journal.Pone.0143504  0.01
2015 Moro SS, Kelly KR, McKetton L, Gallie BL, Steeves JK. Evidence of multisensory plasticity: Asymmetrical medial geniculate body in people with one eye. Neuroimage. Clinical. 9: 513-8. PMID 26594632 DOI: 10.1016/J.Nicl.2015.09.016  1
2015 Ciancetta A, Sabbadin D, Federico S, Spalluto G, Moro S. Advances in Computational Techniques to Study GPCR-Ligand Recognition. Trends in Pharmacological Sciences. 36: 878-90. PMID 26538318 DOI: 10.1016/J.Tips.2015.08.006  0.01
2015 Carta D, Bortolozzi R, Hamel E, Basso G, Moro S, Viola G, Ferlin MG. Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity. Journal of Medicinal Chemistry. 58: 7991-8010. PMID 26418966 DOI: 10.1021/Acs.Jmedchem.5B00805  0.01
2015 Paoletta S, Sabbadin D, von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, Stevens RC, Moro S, Müller CE, Jacobson KA. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. Journal of Computer-Aided Molecular Design. PMID 26194851 DOI: 10.1007/S10822-015-9858-Z  0.01
2015 Sissi C, Moro S, Crothers DM. Novel insights on the DNA interaction of calicheamicin γ₁(I). Biopolymers. 103: 449-59. PMID 25411012 DOI: 10.1002/Bip.22591  0.01
2015 Moscetti I, Faoro F, Moro S, Sabbadin D, Sella L, Favaron F, D'Ovidio R. The xylanase inhibitor TAXI-III counteracts the necrotic activity of a Fusarium graminearum xylanase in vitro and in durum wheat transgenic plants Molecular Plant Pathology. 16: 583-592. DOI: 10.1111/mpp.12215  0.01
2015 Sabbadin D, Ciancetta A, Deganutti G, Cuzzolin A, Moro S. Exploring the recognition pathway at the human A2A adenosine receptor of the endogenous agonist adenosine using supervised molecular dynamics simulations Medchemcomm. 6: 1081-1085. DOI: 10.1039/C5Md00016E  0.01
2015 Deganutti G, Cuzzolin A, Ciancetta A, Moro S. Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 Bioorganic and Medicinal Chemistry. 23: 4065-4071. DOI: 10.1016/j.bmc.2015.03.039  0.01
2015 Sturlese M, Bellanda M, Moro S. NMR-Assisted Molecular Docking Methodologies Molecular Informatics. 34: 513-525. DOI: 10.1002/minf.201500012  0.01
2014 Moro SS, Harris LR, Steeves JK. Optimal audiovisual integration in people with one eye. Multisensory Research. 27: 173-88. PMID 25577901 DOI: 10.1163/22134808-00002453  1
2014 Sabbadin D, Ciancetta A, Moro S. Perturbation of fluid dynamics properties of water molecules during g protein-coupled receptor-ligand recognition: The human A2a adenosine receptor as a key study Journal of Chemical Information and Modeling. 54: 2846-2855. PMID 25245783 DOI: 10.1021/Ci500397Y  0.01
2014 Squarcialupi L, Colotta V, Catarzi D, Varano F, Betti M, Varani K, Vincenzi F, Borea PA, Porta N, Ciancetta A, Moro S. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A 2A adenosine receptors. Molecular modeling and pharmacological studies European Journal of Medicinal Chemistry. 84: 614-627. PMID 25063944 DOI: 10.1016/J.Ejmech.2014.07.060  0.01
2014 Ciancetta A, Cuzzolin A, Moro S. Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: The human adenosine A2A receptor as a case study Journal of Chemical Information and Modeling. 54: 2243-2254. PMID 25046649 DOI: 10.1021/Ci5002857  0.01
2014 Masiero A, Aufiero S, Minervini G, Moro S, Costa R, Tosatto SC. Evaluation of the steric impact of flavin adenine dinucleotide in Drosophila melanogaster cryptochrome function. Biochemical and Biophysical Research Communications. 450: 1606-11. PMID 25026553 DOI: 10.1016/J.Bbrc.2014.07.038  0.01
2014 Federico S, Ciancetta A, Porta N, Redenti S, Pastorin G, Cacciari B, Klotz KN, Moro S, Spalluto G. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5- c ]pyrimidines to explore the antagonist profiling on adenosine receptors: A preliminary structure-activity relationship study Journal of Medicinal Chemistry. 57: 6210-6225. PMID 24972108 DOI: 10.1021/Jm500752H  0.01
2014 Cristiani A, Maset F, De Toni L, Guidolin D, Sabbadin D, Strapazzon G, Moro S, De Filippis V, Foresta C. Carboxylation-dependent conformational changes of human osteocalcin Frontiers in Bioscience - Landmark. 19: 1105-1116. PMID 24896339 DOI: 10.2741/4270  0.01
2014 Frezzato F, Trimarco V, Martini V, Gattazzo C, Ave E, Visentin A, Cabrelle A, Olivieri V, Zambello R, Facco M, Zonta F, Cristiani A, Brunati AM, Moro S, Semenzato G, et al. Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole British Journal of Haematology. 165: 659-672. PMID 24606526 DOI: 10.1111/Bjh.12815  0.01
2014 Sabbadin D, Moro S. Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale Journal of Chemical Information and Modeling. 54: 372-376. PMID 24456045 DOI: 10.1021/Ci400766B  0.01
2014 Sabbadin D, Ciancetta A, Moro S. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: The human A2A adenosine receptor as a key study Journal of Chemical Information and Modeling. 54: 169-183. PMID 24359090 DOI: 10.1021/Ci400532B  0.01
2014 Barollo S, Pezzani R, Cristiani A, Redaelli M, Zambonin L, Rubin B, Bertazza L, Zane M, Mucignat-Caretta C, Bulfone A, Pennelli G, Casal Ide E, Pelizzo MR, Mantero F, Moro S, et al. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations Thyroid. 24: 809-819. PMID 24295088 DOI: 10.1089/Thy.2013.0403  0.01
2013 Moro SS, Steeves JK. No Colavita effect: increasing temporal load maintains equal auditory and visual processing in people with one eye. Neuroscience Letters. 556: 186-90. PMID 24103371 DOI: 10.1016/J.Neulet.2013.09.064  1
2013 Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, Moro S, Hanke N, Hartmann RW, Basso G, Viola G. Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors Journal of Medicinal Chemistry. 56: 7536-7551. PMID 24025069 DOI: 10.1021/Jm400377Z  0.01
2013 Raffaello A, De Stefani D, Sabbadin D, Teardo E, Merli G, Picard A, Checchetto V, Moro S, Szabò I, Rizzuto R. The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit Embo Journal. 32: 2362-2376. PMID 23900286 DOI: 10.1038/Emboj.2013.157  0.01
2013 Minervini G, Masiero A, Moro S, Tosatto SCE. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: A new player in the VHL/HIF-1α interaction pathway? Febs Letters. 587: 2996-3001. PMID 23886708 DOI: 10.1016/J.Febslet.2013.07.019  0.01
2013 Bacilieri M, Ciancetta A, Paoletta S, Federico S, Cosconati S, Cacciari B, Taliani S, Da Settimo F, Novellino E, Klotz KN, Spalluto G, Moro S. Revisiting a receptor-based pharmacophore hypothesis for human A 2A adenosine receptor antagonists Journal of Chemical Information and Modeling. 53: 1620-1637. PMID 23705857 DOI: 10.1021/Ci300615U  0.01
2013 Inamdar GS, Pandya AN, Thakar HM, Sudarsanam V, Kachler S, Sabbadin D, Moro S, Klotz KN, Vasu KK. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides European Journal of Medicinal Chemistry. 63: 924-934. PMID 23685887 DOI: 10.1016/J.Ejmech.2013.03.020  0.01
2013 Pozzi N, Acquasaliente L, Frasson R, Cristiani A, Moro S, Banzato A, Pengo V, Scaglione GL, Arcovito A, De Cristofaro R, De Filippis V. β2-Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions Journal of Thrombosis and Haemostasis. 11: 1093-1102. PMID 23578283 DOI: 10.1111/Jth.12238  0.01
2013 Squarcialupi L, Colotta V, Catarzi D, Varano F, Filacchioni G, Varani K, Corciulo C, Vincenzi F, Borea PA, Ghelardini C, Di Cesare Mannelli L, Ciancetta A, Moro S. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation Journal of Medicinal Chemistry. 56: 2256-2269. PMID 23427825 DOI: 10.1021/Jm400068E  0.01
2013 Kozma E, Jayasekara PS, Squarcialupi L, Paoletta S, Moro S, Federico S, Spalluto G, Jacobson KA. Fluorescent ligands for adenosine receptors. Bioorganic & Medicinal Chemistry Letters. 23: 26-36. PMID 23200243 DOI: 10.1016/J.Bmcl.2012.10.112  0.01
2013 Bortolato A, Fanton M, Mason JS, Moro S. Molecular docking methodologies. Methods in Molecular Biology (Clifton, N.J.). 924: 339-360. PMID 23034755 DOI: 10.1007/978-1-62703-017-5_13  0.01
2013 Cheong SL, Federico S, Venkatesan G, Mandel AL, Shao YM, Moro S, Spalluto G, Pastorin G. The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches Medicinal Research Reviews. 33: 235-335. PMID 22095687 DOI: 10.1002/Med.20254  0.01
2013 Fanton M, Floris M, Cristiani A, Olla S, Medda R, Sabbadin D, Bulfone A, Moro S. MMsDusty: An alternative InChI-based tool to minimize chemical redundancy Molecular Informatics. 32: 681-684. DOI: 10.1002/minf.201300061  0.01
2012 Floris M, Sabbadin D, Medda R, Bulfone A, Moro S. Adenosiland: Walking through adenosine receptors landscape European Journal of Medicinal Chemistry. 58: 248-257. PMID 23127988 DOI: 10.1016/J.Ejmech.2012.10.022  0.01
2012 Federico S, Ciancetta A, Sabbadin D, Paoletta S, Pastorin G, Cacciari B, Klotz KN, Moro S, Spalluto G. Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human A3 adenosine receptor antagonists Journal of Medicinal Chemistry. 55: 9654-9668. PMID 23098605 DOI: 10.1021/Jm300899Q  0.01
2012 Furlanetto V, Zagotto G, Pasquale R, Moro S, Gatto B. Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: An in vitro study Journal of Agricultural and Food Chemistry. 60: 9162-9170. PMID 22924519 DOI: 10.1021/Jf302600Q  0.01
2012 Cozza G, Pinna LA, Moro S. Protein kinase CK2 inhibitors: A patent review Expert Opinion On Therapeutic Patents. 22: 1081-1097. PMID 22908959 DOI: 10.1517/13543776.2012.717615  0.01
2012 Colotta V, Lenzi O, Catarzi D, Varano F, Squarcialupi L, Costagli C, Galli A, Ghelardini C, Pugliese AM, Maraula G, Coppi E, Pellegrini-Giampietro DE, Pedata F, Sabbadin D, Moro S. 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies. European Journal of Medicinal Chemistry. 54: 470-82. PMID 22704999 DOI: 10.1016/J.Ejmech.2012.05.036  0.01
2012 Gaspar A, Reis J, Kachler S, Paoletta S, Uriarte E, Klotz KN, Moro S, Borges F. Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. Biochemical Pharmacology. 84: 21-9. PMID 22433284 DOI: 10.1016/J.Bcp.2012.03.007  0.01
2012 Kozma E, Kumar TS, Federico S, Phan K, Balasubramanian R, Gao ZG, Paoletta S, Moro S, Spalluto G, Jacobson KA. Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. Biochemical Pharmacology. 83: 1552-61. PMID 22402302 DOI: 10.1016/J.Bcp.2012.02.019  0.01
2012 Moro SS, Steeves JK. No Colavita effect: equal auditory and visual processing in people with one eye. Experimental Brain Research. 216: 367-73. PMID 22105335 DOI: 10.1007/S00221-011-2940-4  1
2012 Girolami A, Scarparo P, Bonamigo E, Santarossa L, Cristiani A, Moro S, Lombardi AM. A cluster of factor XI-deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy European Journal of Haematology. 88: 229-236. PMID 21999818 DOI: 10.1111/J.1600-0609.2011.01723.X  0.01
2012 Viola G, Bortolozzi R, Hamel E, Moro S, Brun P, Castagliuolo I, Ferlin MG, Basso G. MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. Biochemical Pharmacology. 83: 16-26. PMID 21964343 DOI: 10.1016/J.Bcp.2011.09.017  0.01
2012 Floris M, Moro S. Mimicking peptides⋯ in silico Molecular Informatics. 31: 12-20. DOI: 10.1002/minf.201100093  0.01
2011 Bertini S, Asso V, Ghilardi E, Granchi C, Manera C, Minutolo F, Saccomanni G, Bortolato A, Mason J, Moro S, MacChia M. Carbazole-containing arylcarboxamides as BACE1 inhibitors Bioorganic and Medicinal Chemistry Letters. 21: 6657-6661. PMID 21986588 DOI: 10.1016/J.Bmcl.2011.09.064  0.01
2011 Cozza G, Gianoncelli A, Bonvini P, Zorzi E, Pasquale R, Rosolen A, Pinna LA, Meggio F, Zagotto G, Moro S. Urolithin as a Converging Scaffold Linking Ellagic acid and Coumarin Analogues: Design of Potent Protein Kinase CK2 Inhibitors Chemmedchem. 6: 2273-2286. PMID 21972104 DOI: 10.1002/Cmdc.201100338  0.01
2011 Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, Enzo E, Moro S, Polo S, Dupont S, Cordenonsi M, Piccolo S. USP15 is a deubiquitylating enzyme for receptor-activated SMADs Nature Cell Biology. 13: 1368-1375. PMID 21947082 DOI: 10.1038/Ncb2346  0.01
2011 Pendin D, Tosetto J, Moss TJ, Andreazza C, Moro S, McNew JA, Daga A. GTP-dependent packing of a three-helix bundle is required for atlastin-mediated fusion Proceedings of the National Academy of Sciences of the United States of America. 108: 16283-16288. PMID 21930898 DOI: 10.1073/Pnas.1106421108  0.01
2011 Cheong SL, Dolzhenko AV, Paoletta S, Lee EPR, Kachler S, Federico S, Klotz KN, Spalluto G, Moro S, Pastorin G. Does the combination of optimal substitutions at the C 2-, N 5- and N 8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A 3 adenosine receptors? Bioorganic and Medicinal Chemistry. 19: 6120-6134. PMID 21908194 DOI: 10.1016/J.Bmc.2011.08.026  0.01
2011 Quintieri L, Palatini P, Moro S, Floreani M. Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin Drug Metabolism and Pharmacokinetics. 26: 559-568. PMID 21791871 DOI: 10.2133/Dmpk.Dmpk-11-Rg-048  0.01
2011 Cristiani A, Brisotto N, Cedrati FC, Floris M, Scapozza L, Moro S. ClickMD: An intuitive web-oriented molecular dynamics platform Future Medicinal Chemistry. 3: 923-931. PMID 21707396 DOI: 10.4155/Fmc.11.59  0.01
2011 Cozza G, Meggio F, Moro S. The dark side of protein kinase CK2 inhibition Current Medicinal Chemistry. 18: 2867-2884. PMID 21651492 DOI: 10.2174/092986711796150423  0.01
2011 Floris M, Masciocchi J, Fanton M, Moro S. Swimming into peptidomimetic chemical space using pepMMsMIMIC Nucleic Acids Research. 39: W261-W269. PMID 21622954 DOI: 10.1093/Nar/Gkr287  0.01
2011 Cristiani A, Costa G, Cozza G, Meggio F, Scapozza L, Moro S. The Role of the N-Terminal Domain in the Regulation of the "Constitutively Active" Conformation of Protein Kinase CK2α: Insight from a Molecular Dynamics Investigation Chemmedchem. 6: 1207-1216. PMID 21591262 DOI: 10.1002/Cmdc.201100046  0.01
2011 Bacilieri M, Naggi A, Ceol M, Schleicher ED, Tosetto E, Comoli M, Torri G, Moro S, Palumbo M, Gambaro G. Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations. Glycobiology. 21: 1029-37. PMID 21493663 DOI: 10.1093/Glycob/Cwr038  0.01
2011 Poli D, Catarzi D, Colotta V, Varano F, Filacchioni G, Daniele S, Trincavelli L, Martini C, Paoletta S, Moro S. The identification of the 2-phenylphthalazin-1(2 H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A 3 adenosine receptor antagonists Journal of Medicinal Chemistry. 54: 2102-2113. PMID 21401121 DOI: 10.1021/Jm101328N  0.01
2011 Federico S, Paoletta S, Cheong SL, Pastorin G, Cacciari B, Stragliotto S, Klotz KN, Siegel J, Gao ZG, Jacobson KA, Moro S, Spalluto G. Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility. Journal of Medicinal Chemistry. 54: 877-89. PMID 21214204 DOI: 10.1021/Jm101349U  0.01
2011 Marino SM, Fogal S, Bisaglia M, Moro S, Scartabelli G, De Gioia L, Spada A, Monzani E, Casella L, Mammi S, Bubacco L. Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols. Archives of Biochemistry and Biophysics. 505: 67-74. PMID 20875779 DOI: 10.1016/J.Abb.2010.09.019  0.01
2011 Moro S, Restelli GL, Arrighi S, Moretti V, Bontempo V, Rizzi R, Stella A, Pagnacco G. Genetic and environmental effects on a meat spotting defect in seasoned dry-cured ham Italian Journal of Animal Science. 10: 33-37. DOI: 10.4081/ijas.2011.e7  0.01
2011 Bacilieri M, Paoletta S, Basili S, Fanton M, Moro S. A novel generalized 3D-QSAR model of camptothecin analogs Molecular Informatics. 30: 927-938. DOI: 10.1002/minf.201100060  0.01
2010 Samorì C, Beretta GL, Varchi G, Guerrini A, Di Micco S, Basili S, Bifulco G, Riccio R, Moro S, Bombardelli E, Zunino F, Fontana G. Structure-activity relationship study of 16 a-thiocamptothecins: an integrated in vitro and in silico approach. Chemmedchem. 5: 2006-15. PMID 21069656 DOI: 10.1002/Cmdc.201000369  0.01
2010 Paoletta S, Federico S, Spalluto G, Moro S. Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agents. Methods in Enzymology. 485: 225-44. PMID 21050920 DOI: 10.1016/B978-0-12-381296-4.00013-0  0.01
2010 Bertini S, Ghilardi E, Asso V, Granchi C, Minutolo F, Pineschi M, Di Bussolo V, Bortolato A, Moro S, Saba A, Macchia M. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides. Bioorganic & Medicinal Chemistry. 18: 7991-6. PMID 20934348 DOI: 10.1016/J.Bmc.2010.09.032  0.01
2010 Quintieri L, Bortolozzo S, Stragliotto S, Moro S, Pavanetto M, Nassi A, Palatini P, Floreani M. Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. Drug Metabolism and Pharmacokinetics. 25: 466-76. PMID 20877134 DOI: 10.2133/Dmpk.Dmpk-10-Rg-044  0.01
2010 Michielan L, Moro S. Pharmaceutical perspectives of nonlinear QSAR strategies. Journal of Chemical Information and Modeling. 50: 961-78. PMID 20527756 DOI: 10.1021/Ci100072Z  0.01
2010 Gianoncelli A, Basili S, Scalabrin M, Sosic A, Moro S, Zagotto G, Palumbo M, Gresh N, Gatto B. Rational design, synthesis, and DNA binding properties of novel sequence-selective peptidyl congeners of ametantrone. Chemmedchem. 5: 1080-91. PMID 20458714 DOI: 10.1002/Cmdc.201000106  0.01
2010 Cheong SL, Dolzhenko A, Kachler S, Paoletta S, Federico S, Cacciari B, Dolzhenko A, Klotz KN, Moro S, Spalluto G, Pastorin G. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition. Journal of Medicinal Chemistry. 53: 3361-75. PMID 20307065 DOI: 10.1021/Jm100049F  0.01
2010 Pastorin G, Federico S, Paoletta S, Corradino M, Cateni F, Cacciari B, Klotz KN, Gao ZG, Jacobson KA, Spalluto G, Moro S. Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process. Bioorganic & Medicinal Chemistry. 18: 2524-36. PMID 20304654 DOI: 10.1016/J.Bmc.2010.02.039  0.01
2010 Cozza G, Bortolato A, Moro S. How druggable is protein kinase CK2? Medicinal Research Reviews. 30: 419-62. PMID 19526464 DOI: 10.1002/Med.20164  0.01
2010 Piovan A, Cozza G, Caniato R, Moro S, Filippini R. A novel glucosyltransferase from Catharanthus roseus cell suspensions Process Biochemistry. 45: 655-659. DOI: 10.1016/J.Procbio.2009.12.014  0.01
2010 Michielan L, Pireddu L, Floris M, Moro S. Support vector machine (SVM) as alternative tool to assign acute aquatic toxicity warning labels to chemicals Molecular Informatics. 29: 51-64. DOI: 10.1002/minf.200900005  0.01
2009 Morizzo E, Federico S, Spalluto G, Moro S. Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technology. Current Pharmaceutical Design. 15: 4069-84. PMID 20028322 DOI: 10.2174/138161209789824777  0.01
2009 Moro S. In silico approaches in G protein-coupled receptors (GPCRs) drug discovery: quo vadis? Current Pharmaceutical Design. 15: 3992-3. PMID 20028317 DOI: 10.2174/138161209789824812  0.01
2009 Michielan L, Stephanie F, Terfloth L, Hristozov D, Cacciari B, Klotz KN, Spalluto G, Gasteiger J, Moro S. Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study. Journal of Chemical Information and Modeling. 49: 2820-36. PMID 19908874 DOI: 10.1021/Ci900311J  0.01
2009 Michielan L, Terfloth L, Gasteiger J, Moro S. Comparison of multilabel and single-label classification applied to the prediction of the isoform specificity of cytochrome p450 substrates. Journal of Chemical Information and Modeling. 49: 2588-605. PMID 19883102 DOI: 10.1021/Ci900299A  0.01
2009 Cozza G, Bortolato A, Menta E, Cavalletti E, Spinelli S, Moro S. ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry. 9: 778-86. PMID 19799530 DOI: 10.2174/187152009789056930  0.01
2009 Lenzi O, Colotta V, Catarzi D, Varano F, Poli D, Filacchioni G, Varani K, Vincenzi F, Borea PA, Paoletta S, Morizzo E, Moro S. 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition. Journal of Medicinal Chemistry. 52: 7640-52. PMID 19743865 DOI: 10.1021/Jm900718W  0.01
2009 Samorì C, Guerrini A, Varchi G, Fontana G, Bombardelli E, Tinelli S, Beretta GL, Basili S, Moro S, Zunino F, Battaglia A. Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins. Journal of Medicinal Chemistry. 52: 1029-39. PMID 19530720 DOI: 10.1021/Jm801153Y  0.01
2009 Michielan L, Bolcato C, Federico S, Cacciari B, Bacilieri M, Klotz KN, Kachler S, Pastorin G, Cardin R, Sperduti A, Spalluto G, Moro S. Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites. Bioorganic & Medicinal Chemistry. 17: 5259-74. PMID 19501513 DOI: 10.1016/J.Bmc.2009.05.038  0.01
2009 Lebska M, Szczegielniak J, Dobrowolska G, Cozza G, Moro S, Muszyńska G. A novel splicing variant encoding putative catalytic alpha subunit of maize protein kinase CK2. Physiologia Plantarum. 136: 251-63. PMID 19470094 DOI: 10.1111/J.1399-3054.2009.01238.X  0.01
2009 Basili S, Moro S. Novel camptothecin derivatives as topoisomerase I inhibitors. Expert Opinion On Therapeutic Patents. 19: 555-74. PMID 19441934 DOI: 10.1517/13543770902773437  0.01
2009 Cozza G, Mazzorana M, Papinutto E, Bain J, Elliott M, di Maira G, Gianoncelli A, Pagano MA, Sarno S, Ruzzene M, Battistutta R, Meggio F, Moro S, Zagotto G, Pinna LA. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. The Biochemical Journal. 421: 387-95. PMID 19432557 DOI: 10.1042/Bj20090069  0.01
2009 Colotta V, Lenzi O, Catarzi D, Varano F, Filacchioni G, Martini C, Trincavelli L, Ciampi O, Pugliese AM, Traini C, Pedata F, Morizzo E, Moro S. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies. Journal of Medicinal Chemistry. 52: 2407-19. PMID 19301821 DOI: 10.1021/Jm8014876  0.01
2009 Richter SN, Menegazzo I, Nadai M, Moro S, Palumbo M. Reactivity of clerocidin towards adenine: implications for base-modulated DNA damage. Organic & Biomolecular Chemistry. 7: 976-85. PMID 19225681 DOI: 10.1039/B819049F  0.01
2009 Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, Inui M, Moro S, Modena N, Argenton F, Newfeld SJ, et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell. 136: 123-35. PMID 19135894 DOI: 10.1016/J.Cell.2008.10.051  0.01
2009 Masciocchi J, Frau G, Fanton M, Sturlese M, Floris M, Pireddu L, Palla P, Cedrati F, Rodriguez-Tomé P, Moro S. MMsINC: a large-scale chemoinformatics database. Nucleic Acids Research. 37: D284-90. PMID 18931373 DOI: 10.1093/Nar/Gkn727  0.01
Show low-probability matches.